To require the Secretary of Health and Human Services to approve a risk evaluation and mitigation strategy for mifepristone that is identical to the strategy previously approved, and for other purposes.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. Senate. Restoring Safeguards for Dangerous Abortion Drugs Act. S. 1631. 119th
Cong., 1st
sess., Introduced in Senate May 6, 2025. https://www.govinfo.gov/app/details/BILLS-119s1631is.
APA
Congress, Senate (2025, May 6). Restoring Safeguards for Dangerous Abortion Drugs Act (S. 1631 (IS)). Retrieved from https://www.govinfo.gov/app/details/BILLS-119s1631is.
MLA
United States, Congress, Senate. Restoring Safeguards for Dangerous Abortion Drugs Act. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-119s1631is. 119th Congress, S. 1631, Introduced in Senate 6 May. 2025.
Bluebook
S.1631 - 119th Congress (2025-2026): Restoring Safeguards for Dangerous Abortion Drugs Act, S.1631, 119th Cong. (2025), https://www.govinfo.gov/app/details/BILLS-119s1631is.
